RANI logo

Rani Therapeutics Holdings, Inc.

RANI
Healthcare|Biotechnology|US
$0.55
+0.03 (+5.93%)
DCF Value
$0.33
Tangible Book / Share
$0.26
Cash / Share
$0.29
Next Earnings Report
Mar 31, 2027
EPS est. -$0.05 · Revenue est. $1.6M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest May 27, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Dec 2026
Est. completion
P1Obesity
An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.
NCT06891287n=60

Recent Press Releases

Rani Therapeutics to Participate in the Chardan Healthcare Conference
Oct 13, 2026 · GlobeNewsWire
Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
Oct 5, 2026 · GlobeNewsWire
Rani Therapeutics to Participate in Upcoming September Conferences
Sep 8, 2026 · GlobeNewsWire
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update
Aug 13, 2026 · GlobeNewsWire
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
Aug 10, 2026 · GlobeNewsWire

SEC Filings (75)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jul 31, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 15, 2026S-8Employee stock planDocumentIndex
Jun 30, 20268-KMaterial eventDocumentIndex
May 29, 20268-KMaterial eventDocumentIndex
May 28, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 27, 20268-KMaterial eventDocumentIndex
May 27, 2026424B5Offering prospectusDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 15, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 16, 2026ARSAnnual report to holdersDocumentIndex
Apr 16, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 16, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 26, 2026S-8Employee stock planDocumentIndex
Mar 26, 202610-KAnnual reportDocumentIndex
Mar 26, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 2, 20268-KMaterial eventDocumentIndex
Dec 5, 2025DEF 14CDocumentIndex
Dec 3, 2025EFFECTDocumentIndex
Dec 3, 2025424B5Offering prospectusDocumentIndex
Nov 25, 2025PRE 14CDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 10, 2025DDocumentIndex
Nov 7, 2025S-3Shelf registrationDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 30, 2025SC 13DActivist / 5%+ stakeDocumentIndex
Oct 30, 2025SC 13GPassive 5%+ stakeDocumentIndex
Oct 27, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Oct 27, 20258-KMaterial eventDocumentIndex
Oct 23, 2025SC 13GPassive 5%+ stakeDocumentIndex